Women with higher blood levels of two common per- and polyfluoroalkyl substances, also familiarly known as PFAS, were more likely to develop estrogen receptor-negative, or ER-negative, breast cancer, according to a new study by the National Institutes of Health (NIH), part of the U.S. Department of Health and Human Services (HHS). PFAS are a large group of chemicals used in common consumer…
LAS CRUCES, NM — Emily Chaddock had hired a photographer to capture her in the classic maternity pose. But days later, at 27 weeks pregnant, she developed severe preeclampsia.
(MedPage Today) -- The following contains links to social media websites including Bluesky, X, TikTok, Instagram, Facebook, and LinkedIn. Which medical TV show is most accurate?
A group of psychologists has launched a petition to create a Division of Psychedelic Science and Practice within the American Psychological Association, arguing the field is now an enduring area of…
Regulators finalized a rule Wednesday that would slash payments for drugs in the controversial 340B program and equalize some payments between care sites. Hospitals railed against the rule.
Nine patients who have received Novartis' spinal muscular gene therapy Zolgensma have developed tumors following their treatment, the company confirmed Thursday.
